BlackRock Group’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$114K Buy
158
+22
+16% +$15.2K ﹤0.01% 2806
2016
Q3
$100K Sell
136
-118
-46% -$95.5K ﹤0.01% 2818
2016
Q2
$211K Sell
254
-4
-2% -$3.72K ﹤0.01% 2566
2016
Q1
$213K Buy
258
+187
+263% +$147K ﹤0.01% 2557
2015
Q4
$79K Hold
71
﹤0.01% 2745
2015
Q3
$60K Buy
+71
New +$103K ﹤0.01% 2821
2014
Q4
Sell
-15
Closed -$15K 2907
2014
Q3
$15K Buy
+15
New +$16.9K ﹤0.01% 2772
2014
Q2
Sell
-75
Closed -$105K 2860
2014
Q1
$105K Hold
75
﹤0.01% 2566
2013
Q4
$87K Buy
+75
New +$103K ﹤0.01% 2501

Other funds holding RMTI

BlackRock Group's RMTI Position: Q4 2016 in Review

BlackRock Group increased its Rockwell Medical (RMTI) stake by 16% in Q4 2016, buying an estimated $15.2K and bringing the position to 158 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #2806.

BlackRock Group first reported a position in RMTI in Q4 2013 and has held it in 9 quarters since. The position peaked at $213K in Q1 2016. 85 funds tracked by Wall St. Rank hold RMTI as of Q4 2016.

  • BlackRock Group held 158 shares of Rockwell Medical worth $114K as of Q4 2016.
  • BlackRock Group bought 22 Rockwell Medical shares in Q4 2016, an estimated $15.2K.
  • Rockwell Medical made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2806 holding.
  • BlackRock Group first reported a position in Rockwell Medical in Q4 2013 and has held it in 9 quarters since.
  • BlackRock Group's Rockwell Medical position peaked at $213K in Q1 2016.
  • 85 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.